The biosimulation market is driven by the rising complexity of drug development, increasing demand for cost-efficient R&D processes, and growing adoption of modeling and simulation tools. North America leads the market, while Asia-Pacific is emerging as a high-growth region.
Hyderabad, India, May 04, 2026 (GLOBE NEWSWIRE) — According to the latest report by Mordor Intelligence, the biosimulation market size is expected to grow from USD 5.22 billion in 2026 to USD 11.3 billion by 2031, registering a CAGR of 16.72% during the forecast period (2026–2031). This growth is supported by the increasing reliance on computational tools to enhance drug discovery and development efficiency. Market expansion is driven by the need to reduce clinical trial costs, improve success rates, and accelerate time-to-market for new therapeutics. Pharmaceutical and biotechnology companies are increasingly integrating biosimulation technologies into their research workflows to gain predictive insights and streamline development processes.
The market is expanding as the pharmaceutical industry faces rising R&D costs and high failure rates in clinical trials. Biosimulation enables researchers to model biological systems, predict drug interactions, and optimize dosing strategies before human trials, significantly improving efficiency. Additionally, the increasing focus on precision medicine is encouraging the use of biosimulation tools to develop personalized treatment approaches tailored to individual patient characteristics. Regulatory agencies are also supporting the use of modeling and simulation data in drug approval processes, further strengthening market adoption.
Technological advancements are playing a crucial role in shaping the biosimulation market. The integration of artificial intelligence, machine learning, and advanced data analytics is enhancing the accuracy and scalability of simulation models. These innovations allow for better understanding of complex biological interactions, improving decision-making across preclinical and clinical stages. Furthermore, cloud-based platforms and collaborative research environments are enabling wider accessibility and adoption of biosimulation tools across organizations.
Biosimulation Market Share by Region
North America represents a significant share of the biosimulation market, driven by strong investment in pharmaceutical research, advanced technological infrastructure, and early adoption of innovative solutions.
Asia-Pacific is emerging as a high-growth region due to expanding pharmaceutical and biotechnology sectors, rising healthcare investments, and growing awareness of advanced research technologies in countries such as China, India, and Japan
Europe holds a notable position in the market, supported by increasing collaboration between academic institutions and industry players, along with supportive regulatory frameworks encouraging simulation-based approaches.
Soumya Goud, Senior Research Manager, Mordor Intelligence, says, “Industry data suggests biosimulation adoption is progressing in line with evolving development requirements and cost-efficiency considerations. Mordor Intelligence relies on cross-verified sources and structured analytical frameworks, helping ensure outputs remain balanced, transparent, and suitable for executive-level evaluation.”
Biosimulation Market Trends & Forecast
Rising Adoption of Modeling and Simulation in Drug Development
Pharmaceutical companies are increasingly using biosimulation tools to improve drug development efficiency, reduce costs, and enhance success rates in clinical trials.
Integration of Artificial Intelligence in Biosimulation
Advanced AI and machine learning technologies are being incorporated into biosimulation platforms to enhance predictive accuracy and support complex data analysis.
Biosimulation Market Segmentation Overview
By Product
• Software
• Services
By Delivery Model
• Subscription
• Ownership / On-premise
By Application
• Pre-clinical & Clinical Drug Development
• Drug Discovery & Lead Optimization
• Precision-medicine & Companion-diagnostics Design
By End User
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Academic & Research Institutes
By Geography
• North America
• United States
• Canada
• Mexico
• Europe
• Germany
• United Kingdom
• France
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia-Pacific
• Middle East & Africa
• GCC
• South Africa
• Rest of Middle East & Africa
• South America
• Brazil
• Argentina
• Rest of South America
For a full breakdown of market dynamics, segmentation insights, regional analysis, and competitive landscape, access the details of the Mordor Intelligence report: https://www.mordorintelligence.com/industry-reports/global-biosimulation-market-industry?utm_source=globenewswire
Biosimulation Market Competitive Outlook
The biosimulation market features global technology providers, pharmaceutical companies, and specialized solution vendors focusing on enhancing simulation capabilities and expanding application areas. Market participants are investing in advanced analytics, AI integration, and cloud-based platforms to strengthen their offerings and support complex drug development processes. Strategic collaborations and partnerships are also playing a key role in expanding market presence and accelerating innovation.
Major Companies in the biosimulation market include:
- Certara USA, Inc.
- Simulations Plus, Inc.
- Dassault Systèmes
- Schrödinger, Inc.
- Genedata AG
Check out related reports published by Mordor Intelligence:
Long-Term Care Software Market Size – The long-term care software market is expected to grow from USD 6.13 billion in 2026 to USD 9.49 billion by 2031, registering a CAGR of 9.13% during the forecast period. Growth is driven by increasing demand for efficient patient data management, rising adoption of digital healthcare solutions in long-term care facilities, and growing need for regulatory compliance and workflow optimization.
McKesson Corporation, Allscripts Healthcare Solutions, Netsmart Technologies Inc., Cerner Corporation (Oracle) and Epic Systems Corporation are the major companies operating in this market.
Read more about companies in the long-term care software market: https://www.mordorintelligence.com/industry-reports/long-term-care-software-market/companies?utm_source=globenewswire
Nurse Call Systems Market Share – The nurse call systems market is expected to grow from USD 2.69 billion in 2026 to USD 4.31 billion by 2031, registering a CAGR of 9.88% during the forecast period. Market expansion is supported by increasing focus on patient safety, rising adoption of advanced communication systems in hospitals, and growing demand for real-time patient monitoring solutions.
Tele Intensive Care Unit Market Trends – The tele intensive care unit market is estimated to grow from USD 5.52 billion in 2026 to USD 11.01 billion by 2031, registering a CAGR of 14.81% during the forecast period. Growth is driven by increasing demand for remote critical care services, rising adoption of telehealth technologies, and growing need to improve access to specialized intensive care expertise.
Read about Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
CONTACT: For any inquiries, please contact: media@mordorintelligence.com https://www.mordorintelligence.com/contact-us